目次

1. Report Overview
1.1 Introduction to Clinical Trials Supply and Logistics Market
1.1.1 Sponsors And Contract Research Firms Involved In Drug Discovery Have Recognised The Importance Of Clinical Trials Logistics
1.1.2 Clinical Trials Are Time-Consuming Endeavours That Necessitate The Coordination Of Numerous Roles And Processes.
1.1.3 The Global Clinical Trials Supply Market Is Booming, Due To Rising Prevalence Of Chronic Diseases
1.1.4 Many pharmaceutical companies Are Quickly Adopting DTP Model
1.2 Global Clinical Trial Supply and Logistics Market Definition
1.3 Direct-to-Patient Model
1.4 Why You Should Read This Report
1.5 What This Report Delivers
1.6 Key Questions Answered By This Analytical Report Include:
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQs)
1.10 Associated Visiongain Reports
1.11 About Visiongain

2 Executive Summary
2.1 Europe Is Largest Market Segment Because Innovative And Unique Therapeutic Choices Are In High Demand
2.2 The Logistics And Distribution Segment Dominated The Entire Clinical Trial Materials And Supplies Market
2.3 DTP Clinical Trials Will Continue To Be A Viable Option Beyond The Pandemic

3 Market Dynamics
3.1 Market Driving Factors
3.1.1 One Of The Factors Driving The Clinical Trial Supply And Logistics Market Will Be The Demand For Biological And Orphan Drugs
3.1.2 Increasing innovations in Clinical trial supply and logistics
3.1.3 Pharmaceutical and Biotech firms entering into strategic partnerships with Supply and logistics providers and CROs
3.1.4 Rapid Growth in Market Due to Covid-19 Pandemic
3.1.5 Increased R&D investments and government support expanded the research possibilities
3.1.6 Globalization of Clinical Trials:
3.1.7 DTP Model May Help To Boost Patient Retention
3.1.8 Adopting DTP Elements In Clinical Trials Can Help Improve The Patient Experience During The Entire Process
3.2 Market Restrainting Factors
3.2.1 High Financial Cost
3.2.2 DTP Not Be Fit For All Clinical Trial Studies
3.2.3 Clinical Trial Length Is Influenced By A Number Of Factors
3.2.4 Several Technology Advancements And Chances For Centralised Coordination Have The Potential To Reduce Drug Development Schedules
3.2.5 Difficulties In Recruiting And Retaining Participants
3.2.6 There Are Various Issues Unique To Certain Illness Regions Or Trial Types That Can Make Recruiting And Retaining Participants In Sufficient Numbers Particularly Difficult
3.2.7 Increasing Competition For Qualified Investigators And Sites
3.2.8 Sponsors' Experiences With The Competition Are Influenced To Some Extent By The Size Of Their Company And The Diseases They Specialise In
3.3 Opportunities in the Global Market
3.3.1 AI and Machine Learning are Evolving with More Data
3.3.2 Virtual Trials And Technology Are Gaining Acceptance Among Patients And Sites
3.3.3 Big Companies are Driving the Market
3.3.4 Advantages of Real-world Clinical Trials
3.3.5 New-Age Clinical Studies
3.4 Challenges
3.4.1 Outsourcing Is One Of The Trends That Is Driving Both Opportunities And Challenges
3.4.2 Lockdowns Have Resulted In Clinical Logistical Challenges
3.4.3 Many Funding Sources with Pros and Cons
3.4.4 Patient Recruitment/Access
3.4.5 Absence of Proper Communication Channels
3.4.6 Coordinators Working In Global Clinical Trial Logistics Must Be Part Of An Unbiased Team
3.4.7 When There Is A Change In Leadership, Things Start To Fall Apart
3.5 SWOT Analysis
3.6 PEST Analysis
3.6.1 Political Factors
3.6.2 Economic Factors
3.6.3 Sociocultural Factors
3.6.4 Technological Factors
3.7 Porter’s Five Forces Analysis:
3.7.1 Threat of New Entrants
3.7.2 Power of Suppliers
3.7.3 Power of Buyers
3.7.4 Availability of Substitutes
3.7.5 Competitive Rivalry

4 Global Clinical Trials Supply and Logistics Market Analysis
4.1 Global Market Size Estimation and Forecast
4.1.1 Pre-COVID-19 Market Scenario
4.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

5 Global Clinical Trials Supply and Logistics Market By Region
5.1 North America
5.2 Europe
5.3 Asia-Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Global Clinical Trials Supply and Logistics Market By Type
6.1 CTS Manufacturing
6.2 CTS Logistics & Distribution
6.3 CTS Solutions
6.4 CTS Packaging and Storage
6.5 Global Market Size Estimation and Forecast By Type
6.5.1 Pre-COVID-19 Market Scenario
6.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

7 Global Clinical Trials Supply and Logistics Market By Manufacturing
7.1 Investigational Medicinal product (IMP)
7.2 Medical Devices
7.3 Powder Blending & Tableting
7.4 Ancillary Products
7.5 Global Market Size Estimation and Forecast By Manufacturing
7.5.1 Pre-COVID-19 Market Scenario
7.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

8 Global Clinical Trials Supply and Logistics Market By Logistics & Distribution
8.1 CTS Logistics & Distribution
8.2 Medical Devices Transport
8.3 Point-of-Care Devices
8.4 Bedside Diagnostics:
8.5 Ancillary Supplies:
8.6 Global Market Size Estimation and Forecast By Logistics & Distribution
8.6.1 Pre-COVID-19 Market Scenario
8.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

9 Global Clinical Trials Supply and Logistics Market By CT Solutions
9.1 Global Market Size Estimation and Forecast By CT Solutions
9.1.1 Pre-COVID-19 Market Scenario
9.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 Global Clinical Trials Supply and Logistics Market by Packaging & Storage
10.1 Global Market Size Estimation and Forecast By Packaging & Storage
10.1.1 Pre-COVID-19 Market Scenario
10.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

11 Global Market Size Estimation and Forecast by Phase
11.1 Global Market Size Estimation and Forecast By Phase
11.1.1 Pre-COVID-19 Market Scenario
11.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

12 Global Clinical Trial Supply & Logistics Market by Direct-to-Patient Model
12.1 Segment Overview
12.1.1 Depot-to-Patient Model
12.1.2 Site-to-Patient Model
12.1.3 Direct-From-Patient Model
12.1.4 Hybrid Model
12.1.5 Patient Centricity Has Moved To The Forefront Which Is Driving The Adoption Of DTP Services In Virtual Clinical Trials
12.1.6 For Sponsors, DTP Services Can Boost Participation And Retention, And Potentially Lower Trial Costs
12.1.7 Despite DTP Limitations, Clinical Companies are Opting for it
12.1.8 Entrepreneurs Have Faced Inertia From Corporations Who Are Often Unwilling To Take On The Risk Of New Clinical Modalities
12.1.9 The Preferences Of Clinical Research Participants Are Changing, Driving Stakeholders To Build More Virtual, Patient-Centric Approaches.
12.1.10 COVID-19 Places Additional Financial Pressure On Drug Developers
12.1.11 Clinical Trial Delays Can Amount To Significant Losses Ranging From $600,000 To $8 Million Per Day
12.1.12 Digital Tools Can Generate Cost Savings In The Form Of Reduced Investigator Fees, Site Monitoring Costs, Patient Travel Costs, And Improved Patient Retention
12.1.13 The Regulatory Landscape Is Changing, Encouraging The Adoption Of Software-Enabled Clinical Trials
12.1.14 The Coronavirus Vaccine Has Exposed The Inefficiencies In Drug Development Process
12.1.15 FDA Continues To Pave A Path For Clinical Trial Innovation Going Forward
12.1.16 Virtual Control Arms And Real-World Evidence Platforms
12.1.17 Shift Toward Direct-To-Patient (DTP) Deliveries
12.1.18 Sponsors Need To Understand The Challenges Associated With DTP/DFP
12.1.19 Adopting The Decentralized Trial Approach Introduces New Challenges
12.1.20 DTP Clinical Trials Offer Several Benefits To Sponsors And Patients Alike
12.1.21 Real-World Evidence Is Not A New Category Within Pharma IT
12.1.22 The Majority Of RWE Companies Built To Date Focus On Oncology Data
12.1.23 RWE Companies Are Adopting And Evolving
12.1.24 Clinical Supply Chain Optimization Will Be a High Growth Market in Coming Years
12.1.25 Due To The Lack Of Digital Infrastructure, Close To 95% Of Trials Are Delayed
12.1.26 Randomization and Trial Supply Management (RTSM) Technology in Direct-to-Patient Trials
12.1.27 Should The RTSM Include And Address Patient Names Or Are The CMO/Courier Responsible For Coordinating The Process?
12.1.28 CROs Play Crucial Role in DTP Model Clinical Trials
12.2 Global Market Size Estimation and Forecast Analysis
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L- Shaped Recovery Analysis)

13 North America Clinical Trials Supply and Logistics Market Analysis
13.1 North America Market Outlook
13.1.1 Innovation Of Clinical Trials In North American Region Leading to Market Growth:
13.1.2 R&D Investments in North America
13.1.3 DTP/DFP Are Setting up New Standards for upcoming Clinical Trials
13.2 North America Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 North America Market Size Estimation and Forecast By Type
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 North America Market Size Estimation and Forecast By Manufacturing
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 North America Market Size Estimation and Forecast By Logistics & Distribution
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 North America Market Size Estimation and Forecast By CT Solutions
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 North America Market Size Estimation and Forecast By Packaging & Storage
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 North America Market Size Estimation and Forecast By Phase
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 North America Market Size Estimation and Forecast by DTP Model
13.10.1 Pre-COVID-19 Marke Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 US Clinical Trials Supply and Logistics Market Analysis
13.11.1 Demand For Biological Drugs In US:
13.11.2 Innovation In Clinical Trials:
13.11.3 US Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
13.11.4 US Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Canada Clinical Trials Supply and Logistics Market Analysis
13.12.1 Canada Investment In Infrastructure and Education Leading to Market Growth:
13.12.2 Large Investment In Clinical Trials:
13.12.3 Canada Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
13.12.4 Canada Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Mexico Clinical Trials Supply and Logistics Market Analysis
13.13.1 Expansion and Innovation in pharmaceutical Industry:
13.13.2 Building the regulatory framework
13.13.3 Mexico Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
13.13.4 Mexico Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

14 Europe Clinical Trials Supply and Logistics Market Analysis
14.1 Europe Market Outlook
14.1.1 Large Investment in Infrastructure for Clinical Research:
14.1.2 Innovation in Clinical Trials
14.1.3 The Use Of Wearable Technology Is Also Gaining Traction Within Clinical Trials
14.2 Europe Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Europe Market Size Estimation and Forecast By Type
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Europe Market Size Estimation and Forecast By Manufacturing
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Europe Market Size Estimation and Forecast By Logistics & Distribution
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Europe Market Size Estimation and Forecast By CT Solutions
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Europe Market Size Estimation and Forecast By Packaging & Storage
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Europe Market Size Estimation and Forecast By Phase
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 Europe Market Size Estimation and Forecast by DTP Model
14.10.1 Pre-COVID-19 Market Scenario
14.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 Germany Clinical Trials Supply and Logistics Market Analysis
14.11.1 Globalization of Clinical Trials:
14.11.2 R&D Excellence and Innovation
14.11.3 Germany Clinical Trials and Logistics Pre-COVID-19 Market Scenario
14.11.4 Germany Clinical Trials and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 UK Clinical Trials Supply and Logistics Market Analysis
14.12.1 UK is Making Large Investments in Pharmaceutical Market:
14.12.2 Commercial Clinical Research Is Important For The UK, But The Country Is Falling Behind In Large Late-Stage Trials
14.12.3 UK Clinical Trials and Logistics Pre-COVID-19 Market Scenario
14.12.4 UK Clinical Trials and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 France Clinical Trials Supply and Logistics Market Analysis
14.13.1 France Demand for Biological and Orphan Drugs:
14.13.2 France Clinical Trials and Logistics Pre-COVID-19 Market Scenario
14.13.3 France Clinical Trials and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Italy Clinical Trials Supply and Logistics Market Analysis
14.14.1 Italy Innovation in Clinical Trials:
14.14.2 Italy Clinical Trials and Logistics Pre-COVID-19 Market Scenario
14.14.3 Italy Clinical Trials and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Spain Clinical Trials Supply and Logistics Market Analysis
14.15.1 Boost in Research and Development:
14.15.2 Spain Clinical Trials and Logistics Pre-COVID-19 Market Scenario
14.15.3 Spain Clinical Trials and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.16 Rest of Europe Clinical Trials Supply and Logistics Market Analysis
14.16.1 Rest of Europe Clinical Trials and Logistics Pre-COVID-19 Market Scenario
14.16.2 Rest of Europe Clinical Trials and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

15 Asia-Pacific Clinical Trials Supply and Logistics Market Analysis
15.1 Asia-Pacific Market Outlook
15.1.1 Biomedical Research Leading to Economic growth:
15.1.2 Ease in Government Regulation
15.1.3 DTP/DFP Fulfils The Need For Minimal Disruption To The Patient's Lifestyle While Increasing Their Willingness To Participate In A Clinical Trial
15.2 Asia-Pacific Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Country Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 Asia-Pacific Market Size Estimation and Forecast By Type
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 Asia-Pacific Market Size Estimation and Forecast By Manufacturing
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 Asia-Pacific Market Size Estimation and Forecast By Logistics & Distribution
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 Asia-Pacific Market Size Estimation and Forecast By CT Solutions
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 Asia-Pacific Market Size Estimation and Forecast By Packaging & Storage
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 Asia-Pacific Market Size Estimation and Forecast By Phase
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Asia-Pacific Market Size Estimation and Forecast by DTP Model
15.10.1 Pre-COVID-19 Market Scenario
15.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 China Clinical Trials Supply and Logistics Market Analysis
15.11.1 The advantages of being in China for an international CRO
15.11.2 The Chinese regulatory environment
15.11.3 Challenges in clinical development
15.11.4 Short- and long-term goals
15.11.5 China Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
15.11.6 China Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 India Clinical Trials Supply and Logistics Market Analysis
15.12.1 India to Become key Location of Clinical Trials:
15.12.2 Advantages of Conducting Clinical Research Studies in India
15.12.3 India Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
15.12.4 India Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Japan Clinical Trials Supply and Logistics Market Analysis
15.13.1 Collaboration with Neighbouring Countries:
15.13.2 More international clinical trials:
15.13.3 The obstacles to simultaneous drug development:
15.13.4 Japan Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
15.13.5 Japan Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 South Korea Clinical Trials Supply and Logistics Market Analysis
15.14.1 Why South Korea Is The Hottest Growth Spot For Clinical Trials
15.14.2 Simplifying The Regulatory Process
15.14.3 South Korea Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
15.14.4 South Korea Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 Australia Clinical Trials Supply and Logistics Market Analysis
15.15.1 Australia’s clinical trials industry is experiencing ‘unprecedented support’
15.15.2 Australia Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
15.15.3 Australia Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.16 Rest of Asia-Pacific Clinical Trials Supply and Logistics Market Analysis
15.16.1 Rest of Asia-Pacific Clinical Trials Supply and Logistics Pre-COVID-19 Market Scenario
15.16.2 Rest of Asia-Pacific Clinical Trials Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

16 LAMEA Clinical Trials Supply and Logistics Market Analysis
16.1 LAMEA Market Outlook
16.1.1 Innovation of Clinical Trials in LAMEA Market:
16.1.2 Opportunities for clinical research in Latin America
16.1.3 There Is A Large Opportunity For DTP Companies To Connect The Various Stakeholders Involved In Trials
16.1.4 The organization and logistics of shipping is one of the key DtP Model Success
16.2 LAMEA Market Size Estimation and Forecast
16.2.1 Pre-COVID-19 Market Scenario
16.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.3 Country Market Size Estimation and Forecast
16.3.1 Pre-COVID-19 Market Scenario
16.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.4 LAMEA Market Size Estimation and Forecast By Type
16.4.1 Pre-COVID-19 Market Scenario
16.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.5 LAMEA Market Size Estimation and Forecast By Manufacturing
16.5.1 Pre-COVID-19 Market Scenario
16.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.6 LAMEA Market Size Estimation and Forecast By Logistics & Distribution
16.6.1 Pre-COVID-19 Market Scenario
16.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.7 LAMEA Market Size Estimation and Forecast By CT Solutions
16.7.1 Pre-COVID-19 Market Scenario
16.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.8 LAMEA Market Size Estimation and Forecast By Packaging & Storage
16.8.1 Pre-COVID-19 Market Scenario
16.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.9 LAMEA Market Size Estimation and Forecast By Phase
16.9.1 Pre-COVID-19 Market Scenario
16.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.10 LAMEA Market Size Estimation and Forecast by DTP Model
16.10.1 Pre-COVID-19 Market Scenario
16.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.11 Brazil Clinical Trials Supply and Logistics Market Analysis
16.11.1 Brazil Population Driving the Attention Of Pharmaceutical And Biotechnology Companies
16.11.2 Brazil Clinical Trial Supply and Logistics Pre-COVID-19 Market Scenario
16.11.3 Brazil Clinical Trial Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.12 South Africa Clinical Trials Supply and Logistics Market Analysis
16.12.1 Rising Demand In Clinical Trials Around The World
16.12.2 Rising Population And Increased Frequency Of Diseases
16.12.3 South Africa Clinical Trial Supply and Logistics Pre-COVID-19 Market Scenario
16.12.4 South Africa Clinical Trial Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.13 Saudi Arabia Clinical Trials Supply and Logistics Market Analysis
16.13.1 Impact on local investment and the development of healthcare capabilities in Saudi Arabia:
16.13.2 Saudi Arabia Clinical Trial Supply and Logistics Pre-COVID-19 Market Scenario
16.13.3 Saudi Arabia Clinical Trial Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.14 Turkey Clinical Trials Supply and Logistics Market Analysis
16.14.1 Large pharmaceutical business in Turkey:
16.14.2 R&D investment in the Turkish pharmaceutical Market:
16.14.3 Turkey Clinical Trial Supply and Logistics Pre-COVID-19 Market Scenario
16.14.4 Turkey Clinical Trial Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.15 UAE Clinical Trials Supply and Logistics Market Analysis
16.15.1 Clinical Research Organisation is Growing due to Cost Effectiveness and Presence of Big Pharma Companies in UAE Market:
16.15.2 UAE Clinical Trial Supply and Logistics Pre-COVID-19 Market Scenario
16.15.3 UAE Clinical Trial Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16.16 Rest of LAMEA Clinical Trials Supply and Logistics Market Analysis
16.16.1 Rest of LAMEA Clinical Trial Supply and Logistics Pre-COVID-19 Market Scenario
16.16.2 Rest of LAMEA Clinical Trial Supply and Logistics Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

17 Competitive Landscape
17.1 Company Market Share Analysis
17.2 Key Business Strategy Analysis
17.3 New Product/Service Launch as the Key Business Strategy In the Global Market
17.4 Acquisition as the Key Business Strategy In the Global Market
17.5 Partnership as the Key Business Strategy In the Global Market
17.6 Collaboration as the Key Business Strategy In the Global Market
17.7 Expansion as the Key Business Strategy In the Global Market
17.8 Joint Venture as the Key Business Strategy In the Global Market

18 Leading Company Profiles
18.1 Catalent Inc
18.1.1 Company Snapshot
18.1.2 Company Overview
18.1.3 Financial Analysis
18.1.4 Product Benchmarking
18.1.5 Recent Developments
18.2 Thermo Fisher Scientific Inc.
18.2.1 Company Snapshot
18.2.2 Company Overview
18.2.3 Financial Analysis
18.2.4 Product Benchmarking
18.2.5 Recent Developments
18.3 UDG Healthcare Plc
18.3.1 Company Snapshot
18.3.2 Company Overview
18.3.3 Financial Analysis
18.3.4 Product Benchmarking
18.3.5 Recent Developments
18.4 Infosys
18.4.1 Company Snapshot
18.4.2 Company Overview
18.4.3 Financial Analysis
18.4.4 Product Benchmarking
18.4.5 Recent Developments
18.5 PRA Health Sciences
18.5.1 Company Snapshot
18.5.2 Company Overview
18.5.3 Financial Analysis
18.5.4 Product Benchmarking
18.5.5 Recent Developments
18.6 Eurofins Scientific
18.6.1 Company Snapshot
18.6.2 Company Overview
18.6.3 Financial Analysis
18.6.4 Product Benchmarking
18.6.5 Recent Developments
18.7 FedEx
18.7.1 Company Snapshot
18.7.2 Company Overview
18.7.3 Financial Analysis
18.7.4 Product Benchmarking
18.8 United Parcel Services
18.8.1 Company Snapshot
18.8.2 Company Overview
18.8.3 Financial Analysis
18.8.4 Product Benchmarking
18.8.5 Recent Developments
18.9 Kerry Logistics
18.9.1 Company Snapshot
18.9.2 Company Overview
18.9.3 Financial Analysis
18.9.4 Product Benchmarking
18.10 Kuehne + Nagel
18.10.1 Company Snapshot
18.10.2 Company Overview
18.10.3 Financial Analysis
18.10.4 Product Benchmarking
18.10.5 Recent Developments
18.11 Bilcare Limited
18.11.1 Company Snapshot
18.11.2 Company Overview
18.11.3 Financial Analysis
18.11.4 Product Benchmarking
18.12 Mayne Pharma Group Ltd
18.12.1 Company Snapshot
18.12.2 Company Overview
18.12.3 Financial Analysis
18.12.4 Product Benchmarking
18.12.5 Recent Developments
18.13 Intertek Group PLC
18.13.1 Company Snapshot
18.13.2 Company Overview
18.13.3 Financial Analysis
18.13.4 Product Benchmarking
18.13.5 Recent Developments
18.14 Almac Group
18.14.1 Company Snapshot
18.14.2 Company Overview
18.14.3 Product Benchmarking
18.14.4 Recent Developments
18.15 Parexel
18.15.1 Company Snapshot
18.15.2 Company Overview
18.15.3 Product Benchmarking
18.15.4 Recent Developments
18.16 Biocair
18.16.1 Company Snapshot
18.16.2 Company Overview
18.16.3 Product Benchmarking
18.16.4 Recent Developments
18.17 Marken
18.17.1 Company Snapshot
18.17.2 Company Overview
18.17.3 Product Benchmarking
18.17.4 Recent Developments
18.18 PCI Services
18.18.1 Company Snapshot
18.18.2 Company Overview
18.18.3 Product Benchmarking
18.18.4 Recent Developments
18.19 Capsugel
18.19.1 Company Snapshot
18.19.2 Company Overview
18.19.3 Product Benchmarking
18.19.4 Recent Developments
18.20 Movianto
18.20.1 Company Snapshot
18.20.2 Company Overview
18.20.3 Product Benchmarking

19 Conclusion & Recommendations
19.1 Concluding Remarks
19.1.1 Right Logistics Partner Is A Must For Success Of DTP Model
19.2 Recommendations for Market Players

List of Tables
Table 1. Global Clinical Trial Supply and Logistics Market Snapshot, 2021 & 2031 (US$million, CAGR %)
Table 2. Global Clinical Trials Supply and Logistics Market SWOT Analysis 2021-2031
Table 3. Global Clinical Trial Supply & Logistics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 4. Global Clinical Trial Supply & Logistics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 5. Global Clinical Trial Supply & Logistics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 6. Global Clinical Trial Supply & Logistics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 7. Global Clinical Trial Supply & Logistics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 8. Global Clinical Trial Supply & Logistics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Clinical Trial Supply & Logistics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 10. Global Clinical Trial Supply & Logistics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 11. Global Clinical Trial Supply & Logistics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 12. Global Clinical Trial Supply & Logistics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 13. Global Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 15. Global Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 16. Global Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 17. Global Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 18. Global Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 20. Global Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 21. Global Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 22. Global Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 23. Global Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 25. Global Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 26. Global Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 27. Global Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 28. Global Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 30. Global Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 31. Global Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 32. Global Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 33. Global Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 35. Global Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 36. Global Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 37. Global Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 38. Global Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 39. Global Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 40. Global Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 41. Global Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 42. Global Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 43. CRO Tools to Partner with Sponsors in Hybrid/Virtual Trials
Table 44. Global Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 45. Global Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery)
Table 46. Global Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery)
Table 47. Global Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery)
Table 48. Global Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery)
Table 49. North America Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 50. North America Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 51. North America Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 52. North America Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 53. North America Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 54. North America Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 55. North America Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 56. North America Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 57. North America Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 58. North America Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 59. North America Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 60. North America Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 61. North America Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 62. North America Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 63. North America Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 64. North America Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 65. North America Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 66. North America Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 67. North America Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 68. North America Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 69. North America Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 70. North America Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 71. North America Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 72. North America Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 73. North America Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 74. North America Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 75. North America Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 76. North America Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 77. North America Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 78. North America Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 79. North America Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 80. North America Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 81. North America Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 82. North America Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 83. North America Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 84. North America Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 85. North America Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 86. North America Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 87. North America Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 88. North America Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 89. North America Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 90. North America Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery)
Table 91. North America Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery)
Table 92. North America Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery)
Table 93. North America Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery)
Table 94. US Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 95. US Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 96. US Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 97. US Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 98. US Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 99. Canada Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 100. Canada Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 101. Canada Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 102. Canada Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 103. Canada Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 104. Mexico Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 105. Mexico Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 106. Mexico Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 107. Mexico Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 108. Mexico Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 109. Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 110. Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 111. Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 112. Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 113. Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 114. Europe Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 115. Europe Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 116. Europe Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 117. Europe Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 118. Europe Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 119. Europe Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 120. Europe Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 121. Europe Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 122. Europe Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 123. Europe Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 124. Europe Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 125. Europe Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 126. Europe Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 127. Europe Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 128. Europe Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 129. Europe Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 130. Europe Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 131. Europe Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 132. Europe Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 133. Europe Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 134. Europe Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 135. Europe Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 136. Europe Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 137. Europe Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 138. Europe Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 139. Europe Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 140. Europe Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 141. Europe Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 142. Europe Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 143. Europe Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 144. Europe Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 145. Europe Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 146. Europe Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 147. Europe Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 148. Europe Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 149. Europe Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 150. Europe Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery)
Table 151. Europe Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery)
Table 152. Europe Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery)
Table 153. Europe Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery)
Table 154. Germany Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 155. Germany Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 156. Germany Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 157. Germany Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 158. Germany Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 159. UK Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 160. UK Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 161. UK Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 162. UK Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 163. UK Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 164. France Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 165. France Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 166. France Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 167. France Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 168. France Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 169. Italy Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 170. Italy Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 171. Italy Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 172. Italy Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 173. Italy Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 174. Spain Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 175. Spain Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 176. Spain Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 177. Spain Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 178. Spain Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 179. Rest of Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 180. Rest of Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 181. Rest of Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 182. Rest of Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 183. Rest of Europe Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 184. Asia-Pacific Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 185. Asia-Pacific Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 186. Asia-Pacific Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 187. Asia-Pacific Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 188. Asia-Pacific Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 189. Asia-Pacific Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 190. Asia-Pacific Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 191. Asia-Pacific Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 192. Asia-Pacific Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 193. Asia-Pacific Clinical Trial Supply & Logistics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 194. Asia-Pacific Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 195. Asia-Pacific Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 196. Asia-Pacific Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 197. Asia-Pacific Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 198. Asia-Pacific Clinical Trial Supply & Logistics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 199. Asia-Pacific Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 200. Asia-Pacific Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 201. Asia-Pacific Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 202. Asia-Pacific Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 203. Asia-Pacific Clinical Trial Supply Market by Manufacturing, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 204. Asia-Pacific Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 205. Asia-Pacific Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 206. Asia-Pacific Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 207. Asia-Pacific Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 208. Asia-Pacific Clinical Trial Supply Market by Logistics & Distribution, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 209. Asia-Pacific Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 210. Asia-Pacific Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 211. Asia-Pacific Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 212. Asia-Pacific Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 213. Asia-Pacific Clinical Trial Supply & Logistics Market by CT Solutions, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 214. Asia-Pacific Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 215. Asia-Pacific Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 216. Asia-Pacific Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 217. Asia-Pacific Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 218. Asia-Pacific Clinical Trial Supply & Logistics Market by Packaging & Storage, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 219. Asia-Pacific Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 220. Asia-Pacific Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 221. Asia-Pacific Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 222. Asia-Pacific Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 223. Asia-Pacific Clinical Trial Supply & Logistics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 224. Asia-Pacific Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 225. Asia-Pacific Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery)
Table 226. Asia-Pacific Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery)
Table 227. Asia-Pacific Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery)
Table 228. Asia-Pacific Clinical Trial Supply & Logistics Market by DTP Model, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery)
Table 229. China Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 230. China Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 231. China Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 232. China Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 233. China Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 234. India Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 235. India Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 236. India Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 237. India Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 238. India Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 239. Japan Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 240. Japan Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 241. Japan Clinical Trial Supply & Logistics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)